Biotechnology

Kazia calls for greater awareness of the deadliest brain cancer in the US

SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...

2019-07-17 20:00 3891

New England Biolabs®, Inc. opens eighth subsidiary in Australia

IPSWICH, Massachusetts, July 4, 2019 /PRNewswire/ -- New England Biolabs (NEB® ), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia's Life Sciences industry is hom...

2019-07-03 22:00 1656

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

KIRKLAND, Washington, July 1, 2019 /PRNewswire/ --  Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Carillon Mitral Contour System® has been implanted in 1,0...

2019-07-01 19:10 988

WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies

SHANGHAI, June 29, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announces that it has been selected as one of MIT Technology Review's 50 Smartest Companies (TR50) for 2019. WuXi was chosen for its ded...

2019-06-29 13:26 8696

ISTH 2019 Congress: Top Global Experts Convene in Melbourne to Showcase Latest Science and Research

MELBOURNE, June 26, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) will recognize its landmark 50th anniversary as the leader in the field of thrombosis and hemostasis at theISTH 2019 Congress fromJuly 6-10 in Melbourne, Australia. Under the congress theme of ...

2019-06-26 20:00 1030

Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies

SHANGHAI and NEW YORK, June 24, 2019 /PRNewswire/ -- Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capitalize on the rapid internationalization of clinical trials between the US andChina while maintain...

2019-06-25 04:00 1079

Thailand presents the Benefits of Cold Pressed Virgin Rice Bran Oil

BANGKOK, June 24, 2019 /PRNewswire/ -- The Department of Foreign Trade, Ministry of Commerce,Thailand, has introduced a project called "Think RICE, ThinkTHAILAND" to encourage international community to pay attention to consumer health and to raise awareness on the national crop by providing a w...

2019-06-24 20:00 1149

Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019

SEOUL, South Korea, June 21, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it has completed the FDA registration of its nucleic acid extraction instrument, the Seegene STARlet, and will begin offering t...

2019-06-21 20:00 1145

How XAG is Leveraging AI Technology to Transform Agriculture

GENEVA ,Switzerland, June 17, 2019 /PRNewswire/ -- The 3rd AI for Good Global Summit, a leading United Nation platform for multilateral dialogue on Artificial Intelligence (AI), was kicked off inGeneva, Switzerland, May 28-31. As the only Chinese agri-tech company to join the Summit, XAG prese...

2019-06-17 15:48 1413

Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease

SHANGHAI, June 14, 2019 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone) announced today dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively. The Phase II studies ...

2019-06-14 20:30 1372

WuXi NextCODE Clarifications to Public Letter Sent to Department of Health and Human Services Acting Inspector General Joanne M. Chiedi

CAMBRIDGE, Mass., June 11, 2019 /PRNewswire/ -- WuXi NextCODE ("we" or the "Company"), the emerging global standard platform for genomics, today provided the following clarifications to the public letter (the "Letter") sent by the U.S. Senate Finance Committee ChairmanChuck Grassley and Senator M...

2019-06-11 23:07 1562

GT Apeiron Therapeutics launched by GT Healthcare Capital Partners signs with Exscientia

SHANGHAI, June 11, 2019 /PRNewswire/ -- GT Apeiron Therapeutics ("Apeiron"), a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with Exscientia, which utilizes artificial intellige...

2019-06-11 16:00 1315

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...

2019-06-06 18:00 7825

Origin Agritech announces investment agreement with government investor to establish biotech commercialization joint venture.

BEIJING, June 5, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company entered into a Cooperation Framework Agreement with Beijing Changping Technology Innodevelop Group (BC-TI...

2019-06-05 23:42 6884

Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business

PHILADELPHIA, May 31, 2019 /PRNewswire/ -- Iovance Biotherapeutics, a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU). Wu...

2019-05-31 20:00 1912

CartiHeal's Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells

KFAR SABA, Israel, May 30, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of osteochondral and chondral defects, announced today the publication of anin-vitro study demonstrating that the Agili-C™ implant enhances osteogenic differentiation of human...

2019-05-30 20:00 1594

CytoDyn and Samsung BioLogics Formalize Manufacturing Partnership

INCHEON, South Korea, May 30, 2019 /PRNewswire/ -- CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at the Samsung BioLogics Songdo headquarters for an official ...

2019-05-30 19:00 1338

Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization

New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, California, May 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for...

2019-05-30 04:01 1754

Singlera Genomics ColonES test selected as finalist for AACC Disruptive Technology Award

SAN DIEGO, May 29, 2019 /PRNewswire/ -- Singlera Genomics, which focuses on non-invasive early cancer detection through circulating tumor DNA methylation haplotyping analysis, was selected as one of three finalists for the second annual AACC Disruptive Technology Award.  AACC Disruptive Technolo...

2019-05-29 21:00 625

Samsung BioLogics to Showcase End-to-End CDMO Capabilities at BIO International 2019

INCHEON, South Korea, May 28, 2019 /PRNewswire/ -- For the ninth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full end-to-end CDMO capabilities at the BIO International 2019 convention inPhiladelphia, PA, June 3rd to 6th.

2019-05-29 12:27 812
12345 ... 94